Search Results - "Pavlou, H"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Euthyroid Sick Syndrome in Acute Ischemic Syndromes by Pavlou, H.N., Kliridis, P.A., Panagiotopoulos, A.A., Goritsas, C.P., Vassilakos, P.J.

    Published in Angiology (01-11-2002)
    “…The purposes of this study were to assess the occurrence of euthyroid sick syndrome in patients with acute myocardial infarction (AMI) or unstable angina (UA),…”
    Get full text
    Journal Article
  5. 5

    Factors related to sepsis and outcome in multiple trauma patients by Pavlou, H, Pappa, E, Eforakopoulou, M

    Published in Critical care (London, England) (16-03-2015)
    “…Keywords: Public Health, Logistic Regression, Emergency Medicine, General Hospital, Therapeutic Intervention…”
    Get full text
    Journal Article
  6. 6

    Clinical characteristics in surviving and nonsurviving older patients admitted to the ICU by Pappa, E, Pavlou, H, Eforakopoulou, M

    Published in Critical care (London, England) (01-01-2015)
    “…The aim of this study is to determine the clinical characteristics associated with survival of ICU mechanically ventilated older patients. Patients who…”
    Get full text
    Journal Article
  7. 7

    Factors associated with survival of ICU patients with pneumonia caused by multidrug-resistant Gram-negative bacteria by Georgiadou, M, Pappa, E, Papandreou, E, Pavlou, H, Eforakopoulou, M

    Published in Critical care (London, England) (16-03-2015)
    “…Keywords: Pneumonia, Mechanical Ventilation, Significant Risk Factor, Causative Organism, Bacterial Pneumonia…”
    Get full text
    Journal Article
  8. 8

    Genetically‐determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect by Funck‐Brentano, C., Kroemer, HK, Pavlou, H., Woosley, RL, Roden, DM

    Published in British journal of clinical pharmacology (01-04-1989)
    “…1. Quinidine is a potent inhibitor of the genetically‐determined debrisoquine 4‐hydroxylation. Oxidation reactions of several other drugs, including the…”
    Get full text
    Journal Article
  9. 9

    Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias by Turgeon, J, Pavlou, H N, Wong, W, Funck-Brentano, C, Roden, D M

    “…A genetically determined pharmacokinetic and pharmacodynamic interaction between quinidine and single doses of encainide in healthy volunteers has previously…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias by WONG, W, PAVLOU, H. N, BIRGERSDOTTER, U. M, HILLEMAN, D. E, MOHIUDDIN, S. M, RODEN, D. M

    Published in The American journal of cardiology (15-01-1992)
    “…Sematilide, a close structural analog of N-acetylprocainamide, prolongs cardiac action potentials in vitro, whereas it does not depress maximum action…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers by Turgeon, J, Funck-Brentano, C, Gray, H T, Pavlou, H N, Prakash, C, Blair, I A, Roden, D M

    Published in Clinical pharmacology and therapeutics (01-05-1991)
    “…Encainide metabolism is mediated by the polymorphically distributed cytochrome P450IID6, which displays stereoselectivity for some substrates. In this study we…”
    Get more information
    Journal Article
  14. 14

    Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug by Pavlou, H N, Funck-Brentano, C, Lineberry, M D, Woosley, R L, Roden, D M

    Published in Clinical pharmacology and therapeutics (01-03-1991)
    “…In this study we evaluated the clinical pharmacology of intravenous ACC-9358, a new antiarrhythmic drug derived from a Chinese herbal remedy. In a first-study…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18